Last reviewed · How we verify
Hyperhidrosis of axilla
Approved treatments
- Cuvposa · Shionogi
Cuvposa works by blocking the action of a chemical called acetylcholine, which stimulates the muscarinic receptors in the body. - Glycopyrrolate · Yonsei University
- Sialanar · Proveca Pharma Limited
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Hyperhidrosis of axilla patent landscape — cliff calendar, originator estates, attackable patents
- Hyperhidrosis of axilla treatment landscape brief
- Hyperhidrosis of axilla treatment updates RSS
Frequently asked questions about Hyperhidrosis of axilla
What drugs treat Hyperhidrosis of axilla?
Tracked treatments include Cuvposa, Glycopyrrolate, Sialanar.
What is the treatment for Hyperhidrosis of axilla?
Standard treatment for Hyperhidrosis of axilla includes Cuvposa, Glycopyrrolate, Sialanar. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Hyperhidrosis of axilla patent cliff · Hyperhidrosis of axilla CI report
- Treatment: Cuvposa · Shionogi
- Treatment: Glycopyrrolate · Yonsei University
- Treatment: Sialanar · Proveca Pharma Limited
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing